Literature DB >> 3791694

Amount of antibody is critical for immune complex displacement by charge competition from both rabbit glomeruli and anionic beads.

A S Raj, M Tuscan, B Shapiro, A Glatfelter, R Kunkel, R C Wiggins.   

Abstract

The purpose of this study was to determine the feasibility of displacing cationized bovine serum albumin (CBSA) immune complexes from glomeruli by charge competition. An in vitro model identified protamine as an effective agent for displacing 125I-CBSA from anionic beads (dextran sulfate-coated Sepharose 4B). Anti-CBSA serum prevented displacement of 125I-CBSA from anionic beads in a dose-dependent fashion. When 125I-CBSA was injected intravenously into rabbits 98% of 125I-CBSA disappeared from blood within 5 min, at which time CBSA was visualized by immunofluorescence in glomerular capillary walls but not in liver, muscle, skin, spleen or lung. By 24 h 90% of 125I-CBSA had disappeared from glomeruli. In contrast, injection of anti-CBSA antibody caused persistence of 125I-CBSA in kidney (particularly along glomerular capillary walls) for more than 7 days (detected by counting 125I in kidney, by radionuclide imaging and by immunofluorescence). Protamine administration (50 mg intravenously daily for 6 days) caused significant reduction of 125I-CBSA trapped in kidney only if the amount of anti-CBSA injected was small. Protamine did not significantly displace 125I-CBSA from glomeruli if the anti-CBSA dose was larger. Therefore both in vivo and in vitro displacement of 125I-CBSA by protamine depended upon the amount of antibody. We conclude that although charge dependent displacement of immune complexes from glomeruli is probably feasible using protamine this approach would only work in the presence of small amounts of antibody.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3791694      PMCID: PMC1542430     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  The anti-heparin, anticoagulant and hypotensive properties of hexadimethrine and protamine.

Authors:  W S EGERTON; C L ROBINSON
Journal:  Lancet       Date:  1961-09-16       Impact factor: 79.321

2.  Cardiovascular effects of protamine sulfate.

Authors:  B S Goldman; J Joison; W G Austen
Journal:  Ann Thorac Surg       Date:  1969-05       Impact factor: 4.330

3.  Glomerular permeability: in vivo tracer studies with polyanionic and polycationic ferritins.

Authors:  H G Rennke; M A Venkatachalam
Journal:  Kidney Int       Date:  1977-01       Impact factor: 10.612

4.  Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium.

Authors:  M W Seiler; H G Rennke; M A Venkatachalam; R S Cotran
Journal:  Lab Invest       Date:  1977-01       Impact factor: 5.662

5.  Glomerular permeability: transfer of native ferritin in glomeruli with decreased anionic sites.

Authors:  V E Kelley; T Cavallo
Journal:  Lab Invest       Date:  1978-12       Impact factor: 5.662

6.  Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate.

Authors:  C M Bennett; R J Glassock; R L Chang; W M Deen; C R Robertson; B M Brenner; J L Troy; I R ueki; B Rasmussen
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

7.  Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions.

Authors:  R L Chang; W M Deen; C R Robertson; B M Brenner
Journal:  Kidney Int       Date:  1975-10       Impact factor: 10.612

8.  Hepatitis B surface antigen in urine of hemodialysis patients.

Authors:  M R Hourani; G H Mayor; D S Greenbaum; D O Hugget; M J Patterson
Journal:  Kidney Int       Date:  1978-04       Impact factor: 10.612

9.  Permselectivity of the glomerular capillary wall. Facilitated filtration of circulating polycations.

Authors:  M P Bohrer; C Baylis; H D Humes; R J Glassock; C R Robertson; B M Brenner
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

10.  Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins.

Authors:  H G Rennke; R S Cotran; M A Venkatachalam
Journal:  J Cell Biol       Date:  1975-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.